The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer

Francesco Passiglia, Rafael Caparica, Elisa Giovannetti, Marco Giallombardo, Angela Listi, Patrizia Diana, Girolamo Cirrincione, Christian Caglevic, Luis E. Raez, Antonio Russo, Christian Rolfo

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)
Original languageEnglish
Pages (from-to)385-392
JournalExpert opinion on investigational drugs
Issue number4
Publication statusPublished - 2 Apr 2016


  • NTRK-inhibitors
  • NTRK1/2/3
  • TrkA/B/C
  • lung cancer
  • targeted therapy

Cite this